Return
Company Page
Astraea
Founders
Astraea is a Y Combinator-backed agentic AI platform that automates the end-to-end clinical trial biometrics pipeline, converting raw study data into CDISC-compliant datasets, TFLs, and FDA-ready submission outputs. The platform handles SDTM and ADaM mapping, statistical programming, QC, and revision workflows in one auditable system, targeting Phase II and III sponsors in oncology and rare disease. By replacing months of manual statistical programming with AI-driven automation, Astraea dramatically reduces cycle times and CRO costs while keeping human experts in the loop for validation and regulatory decisions.
Company Founded in
Healthtech & Biotech